White Blood Cell Count Nadir and Duration of Aplasia Do Not Associate with Treatment Outcome in Adult Patients with Acute Myeloid Leukemia Undergoing Intensive Chemotherapy

Caocci, Giovanni;La Nasa, Giorgio;
2020-01-01

Abstract

Adult patients with acute myeloid leukemia (AML) are usually treated with intensive chemotherapy, leading to prolonged bone marrow aplasia. It is usually assumed that a short duration of aplasia could be a surrogate marker of poor therapeutic efficacy in clearing bone marrow blasts, especially in older patients. No studies have evaluated the usefulness of such a surrogate marker in younger AML patients treated with intensive chemotherapy.
2020
Inglese
65
3-4
5
Esperti anonimi
scientifica
Acute myeloid leukemia; Aplasia; Intensive chemotherapy; Nadir; White blood cell count
no
Marras, Tatiana; Dettori, Michael; Caocci, Giovanni; La Nasa, Giorgio; Sotgiu, Giovanni; Saderi, Laura; Fozza, Claudio
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
7
reserved
Files in This Item:
File Size Format  
white blood count nadir and duration of aplasia in AML.pdf

Solo gestori archivio

Type: versione editoriale
Size 2.1 MB
Format Adobe PDF
2.1 MB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie